Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
s. pavanello (Padova, Italy), M. Campisi (Padova, Italy), F. Liviero (Padova, Italy), D. Biondini (Padova, Italy), E. Balestro (Padova, Italy), P. Spagnolo (Padova, Italy). A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients. 672

Member's Comments

No comment yet.

Related content which might interest you: Does atorvastatin have effect on lung function and morbidity as add-on therapy in asthmatic patients? Source: Annual Congress 2007 - New drugs for asthma Year: 2007 Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 What influences patient choice of antifibrotic treatment in IPF? Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world Year: 2020 Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 A new method to estimate the long-term effect of immunosuppressants and vasodilator therapies on lung function outcomes in systemic sclerosis patients Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019 Year: 2020 Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003 The effect of corticosteroid use on skeletal muscle function in patients with interstitial lung disease Source: Annual Congress 2012 - The latest insights in integrated care Year: 2012 Assessment of blood biomarkers in patients with IPF under antifibrotic therapy Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function Source: Eur Respir J 2016; 48: 843-851 Year: 2016 Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 433s Year: 2002 Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 The effect of preoperative rehabilitation on pulmonary function in patients with oesophageal cancer Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Anti-inflammatory effects of targeted lung denervation in patients with COPD Source: Eur Respir J 2015; 46: 1489-1492 Year: 2015 The impact of insulin-sensitizers on lung function in COPD Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 The effects of sildenafil on lung function in COPD Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Comment on: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 57 (3) 2004645; 10.1183/13993003.04645-2020 Year: 2021